ARTICLE | Company News
Dovetail, University of Maryland deal
December 18, 2000 8:00 AM UTC
Dovetail acquired an exclusive worldwide license from the university to technology for the design and manufacture of second generation recombinant DNA biopharmaceuticals, and its IFN DT modified inter...